iRhythm CFO Sells $1.66M in Stock Under 10b5-1 Plan
iRhythm Technologies, Inc.
Subscribe to track IRTC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
iRhythm CFO Sells $1.66M in Stock Under 10b5-1 Plan
Company: iRhythm Technologies, Inc. (IRTC) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: Wilson Daniel G. Title: Chief Financial Officer | Relationship: Officer
Transaction: • Type: Sale • Shares: 8,000 • Price: $207.44 • Value: $1,659,520 • Owned After: 26,570
Key Insight: The CFO sold shares valued at $1.66M, representing a very small percentage (0.0275%) of the company's market cap. The sale was pre-scheduled under a 10b5-1 plan, reducing its signaling value.
Market Context: This is a routine, pre-planned transaction with low market impact for a company with a $6.03B market capitalization.
Comprehensive Analysis
SEC Filing Analysis: iRhythm Technologies, Inc. (IRTC)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Financial Officer conducted a pre-planned sale of $1.66 million in stock, a transaction with minimal financial impact on the company.
- Market Impact: Neutral, as the sale is immaterial relative to the company's market capitalization and was executed under a Rule 10b5-1 plan.
Company Information
| Field | Value |
|---|---|
| Company | iRhythm Technologies, Inc. |
| Ticker Symbol | IRTC |
| CIK | 0001388658 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Wilson Daniel G. |
| CIK | 0001860745 |
| Title/Position | Chief Financial Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-31 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 8,000 |
| Price Per Share | $207.44 |
| Total Value | $1,659,520 |
| Shares Owned After | 26,570 (26,470 direct, 100 indirect) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,659,520 |
| % of Market Cap | 0.0275% |
| Shares Transacted | 8,000 |
| % of Shares Outstanding | 0.0249% |
| Post-Transaction Ownership | 26,570 shares (0.083% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $1.66 million transaction is negligible for iRhythm Technologies, a company with a market capitalization of $6.03 billion.
- Ownership Concentration: The CFO's post-sale ownership of 0.083% is not a significant stake in the company.
- Transaction Significance: The sale represents a very small fraction of both the company's market cap and its total shares outstanding, confirming its low significance. The sale constituted approximately 23% of the insider's direct holdings.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction's small size relative to the company's market scale and its pre-scheduled nature under a 10b5-1 plan suggest it is likely motivated by personal financial management rather than a change in the insider's outlook on the company.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction size is too small to have a noticeable impact on daily trading volume.
- Sentiment Indicator: Neutral. Pre-planned sales by executives are common and typically do not influence market sentiment.
Additional Context
Special Circumstances
- This sale was executed under a Rule 10b5-1 trading plan, which was established by the reporting person on November 14, 2024. This indicates the trade was pre-scheduled, significantly reducing its value as a real-time market signal.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
